Search results
Why is the FDA looking to ban this ingredient found in most sodas? - Dexerto
Dexerto· 15 hours agoA common ingredient used in sodas like Mountain Dew and Gatorade in the past has been flagged by the...
FDA monitoring plastic syringe supply chain
Politico· 14 hours agoThe recalls come amid an uptick in product import alerts from the FDA and after the agency’s latest warning to consumers and health care providers not to use the foreign-made ...
Guardant Health Jumps — As Exact Sciences Slumps — On A Key FDA Move For Blood Tests
Investor's Business Daily· 9 hours agoGuardant Health stock jumped Friday after a Food and Drug Administration panel recommended the...
FDA's Draft Guidance On Safety Testing Of Human Allogeneic Cells For Use In Cell-Based Therapies
BioresearchOnline· 23 hours agoIn April 2024, the U.S. FDA released the draft guidance titled Safety Testing of Human Allogeneic...
US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
Reuters· 8 hours agoNovo is aiming to be the first to hit the market with a weekly insulin product, offering an...
FDA Roundup: May 24, 2024
FOX 59 Indianapolis· 10 hours agoOn Thursday, the FDA announced that Medline Industries, LP, a firm marketing and distributing plastic syringes made in China within the U.S., initiated a recall to stop using ...
US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients By Reuters
Investing.com· 9 hours agoNovo is aiming to be the first to hit the market with a weekly insulin product, offering an...
FDA panel backs Guardant’s blood test for colon cancer
MedTech Dive via Yahoo Finance· 18 hours agoWilliam Blair analyst Andrew Brackmann said the FDA appears on its way to approving Shield. Still,...
Blood test to detect colon cancer could move a step closer to FDA approval in the US
WISN 12 Milwaukee· 1 day agoFood and Drug Administration approval of Shield, its blood test to screen for early signs of...
With Duchenne decision ahead, FDA’s Marks pushes for speedy gene therapy approvals
BioPharma Dive via Yahoo Finance· 17 hours agoBut the head of the FDA’s CBER office didn’t tip where the agency stands on potentially broadening...